Mendus Ab Is A Biopharmaceutical Company Based In Swedenformerly Known As Immunicum Abthe Company Is Dedicated To Advancing Cancer Treatment By Focusing On Tumor Recurrence And Enhancing Long Term Survival For Patientsmendus Utilizes Its Expertise In Dendritic Cell Biology To Develop Innovative Immunotherapies That Aim To Activate The Immune System Against Cancer While Maintaining A Benign Safety Profile The Companyae S Lead Products Include Ilixadencelwhich Targets Established Tumors Through Intratumoral Immune Primingand Dcp 001A Cancer Relapse Vaccine Designed To Reduce Tumor Recurrence After Initial Treatmentmendus Operates With A Small Team Of Around 28 Employees And Is Led By Ceo Drerik Mantingwho Has A Strong Background In Immunology And Corporate Financethe Company Is Publicly Traded On The Stockholm Stock Exchange Under The Ticker Immu St
No conferences found for this company.
| Company Name | Dcprime Bv |
| Country |
Netherlands
|
| Address | N/A |
| Telephone | N/A |
| N/A |
